Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose
AssigneeQuorum Bio Co., Ltd.
InventorsHye Eun Kim, Eunju Ryu, Jae Hyun Sim, Jun Sim
Life of this patent
Estimating the term…
Abstract
The present invention relates to use for the prevention and/or alleviation and/or treatment of hypersensitivity immune disease, containing galactose and, more particularly, provides a pharmaceutical composition and a health functional food that comprise galactose for the prevention, amelioration and/or treatment of hypersensitivity immune disease such as atopic dermatitis.
Claims4
A method for treatment or alleviation of immune hypersensitivity-related disease, comprising administering effective amount of a composition consisting of (1) galactose, or (2) galactose and one or more pharmaceutically acceptable or cosmetically acceptable carriers, excipients or diluents selected from the group consisting of fillers, extenders, binders, wetting agents, disintegrating agents, surfactants, sweeteners, flavoring agents, preservatives, oils, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, emulsifiers, propellants and solvents, to a subject in need of treatment or alleviation of the immune hypersensitivity-related disease,
- wherein immune hypersensitivity-related disease is atopic syndrome or atopic dermatitis.
A method of reducing immunoglobulin E, comprising administering a pharmaceutically effective amount of a composition consisting of (1) galactose, or (2) galactose and one or more pharmaceutically acceptable or cosmetically acceptable carriers, excipients or diluents selected from the group consisting of fillers, extenders, binders, wetting agents, disintegrating agents, surfactants, sweeteners, flavoring agents, preservatives, oils, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, emulsifiers, propel-lants and solvents, to a subject in need of reducing immunoglobulin E.
Dependencies are inferred from the claim text.